Patents
Patents for C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
12/2014
12/31/2014CN102603784B 一种拉氧头孢氯化铝(锡)苯甲醚络合物及其制备方法和应用 An Latamoxef aluminum (tin) chloride complexes anisole and its preparation method and application
05/2014
05/08/2014WO2014068388A1 2 substituted cephem compounds
03/2014
03/05/2014CN103619853A Cephem compound having pyridinium group
01/2014
01/30/2014WO2014017797A1 Novel method for preparing 1-oxacephalosporin derivative
08/2013
08/21/2013CN103254215A Preparation method of allyl chlorooxyl cephalosporin compound
07/2013
07/03/2013CN103183688A Preparation method of 7beta-acylamino-7alpha-methoxy-1-oxo-3-cephem compound
07/03/2013CN103183686A Preparation method of 7beta-amino-7lapha-methoxy-3-cephem compound
05/2013
05/29/2013CN102295655B Oxacephem antibiotic intermediate solvate and preparation method thereof
04/2013
04/25/2013US20130102583 Cephem compound having catechol group
03/2013
03/06/2013CN102952149A One-pot synthesis method of flomoxef intermediate
02/2013
02/27/2013CN102942578A Preparation method of 1-oxacephalosporin-3-epoxymethylene derivatives and use of the 1-oxacephalosporin-3-epoxymethylene derivatives in preparation of 1-oxacephalosporin
02/13/2013EP2557082A1 Cephem compound having catechol group
01/2013
01/03/2013WO2013002215A1 Cephem compound having pyridinium group
12/2012
12/19/2012CN102827191A Method for preparing oxygen cephalosporin compound
11/2012
11/21/2012CN101857601B Latamoxef sodium compound with high purity
07/2012
07/25/2012CN102603784A Latamoxef aluminium chloride (stannum)-anisole complex, as well as preparation method and application thereof
06/2012
06/27/2012CN101538274B Method for preparing 1-oxacephalosporin-3-chloromethyl derivatives
05/2012
05/30/2012CN1980939B Process for producing 1-oxacephalosporin-7alpha-methoxy-3-chloromethyl derivative
12/2011
12/28/2011CN102295655A 一种氧头孢烯类抗菌素中间体溶剂化物及其制备方法 Cephem antibiotics an oxygen intermediates solvates and its preparation method
12/06/2011US8071761 Substrates for beta-lactamase and uses thereof
11/2011
11/30/2011CN102260280A 拉氧头孢钠的制备方法 Preparation Latamoxef sodium
09/2011
09/28/2011CN102203100A Cephalosporin having catechol group
08/2011
08/31/2011EP1489061B1 Process for producing cyclic compound
07/2011
07/13/2011CN101440098B Crystal of oxacephem
07/06/2011EP2341053A1 Cephalosporin having catechol group
10/2010
10/13/2010CN101857601A Latamoxef sodium compound with high purity
05/2010
05/06/2010WO2010050468A1 Cephalosporin having catechol group
05/06/2010CA2736953A1 Cepharosporins having a catechol group
09/2009
09/23/2009CN101538274A Method for preparing 1-oxacephalosporin-3-chloromethyl derivatives
07/2009
07/08/2009CN100509819C Crystal of oxacephem
05/2009
05/27/2009CN101440098A Crystal of oxacephem
12/2008
12/03/2008EP1996595A2 PROCESS FOR THE PREPARATION OF (1-OXA- OR l-THIA-)3- CEPHEM DERIVATIVES AND RELATED INTERMEDIATES
12/02/2008US7459551 Method for preparing cyclic compounds
10/2008
10/30/2008WO2007105253A8 PREPARATION OF (1-OXA- OR l-THIA-)3- CEPHEM DERIVATIVES
09/2008
09/24/2008CN101270126A Novel cephalosporin antibiotics and medicine use thereof
09/23/2008US7427680 Fluorogenic substrates for BETA-lactamase gene expression
07/2008
07/24/2008US20080177061 Target for therapy of cognitive impairment
07/08/2008US7396926 Compound for use in the measurement of gene expression
04/2008
04/08/2008US7355040 Process for the preparation of cephalosporin compounds and synthetic intermediates
12/2007
12/06/2007WO2007105253B1 PREPARATION OF (1-OXA- OR l-THIA-)3- CEPHEM DERIVATIVES
11/2007
11/01/2007WO2007105253A3 PREPARATION OF (1-OXA- OR l-THIA-)3- CEPHEM DERIVATIVES
09/2007
09/20/2007WO2007105253A2 PREPARATION OF (1-OXA- OR l-THIA-)3- CEPHEM DERIVATIVES
08/2007
08/09/2007US20070184513 Substrates for beta-lactamase and uses thereof
06/2007
06/13/2007CN1980939A Process for producing 1-oxacephalosporin-7alpha-methoxy-3-chloromethyl derivative
04/2007
04/25/2007CN1312086C Process for producing cyclic compound
03/2007
03/28/2007EP1767538A1 Process for producing 1-oxacephalosporin-7alpha-methoxy-3-chloromethyl derivative
02/2007
02/28/2007CN1922191A Crystal of oxacephem
02/15/2007WO2007017705A1 Process for the preparation of azetidinones
02/13/2007CA2359744C Cephalosporins and homologues preparations and pharmaceutical compositions
01/2007
01/04/2007WO2006085978A3 Conjugates of a cephalosporin derivative and a fluorophor precursor and related compounds as substrates for beta-lactamase gene expression
01/02/2007US7157575 Measuring gene expression
08/2006
08/17/2006WO2006085978A2 Conjugates of a cephalosporin derivative and a fluorophor precursor and related compounds as substrates for beta-lactamase gene expression
01/2006
01/19/2006WO2006006290A1 PROCESS FOR PRODUCING 1-OXACEPHALOSPORIN-7α-METHOXY-3-CHLOROMETHYL DERIVATIVE
09/2005
09/22/2005US20050209450 High yield for industrial production; beta -lactam antibacterial agents; allyl (5R,6S)-6((R)-1-t-butyldimethyl-silyloxyethyl)-7-oxo-3-((R)-2-tetrahydrofuryl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate (3-2)
08/2005
08/18/2005US20050181469 Beta-lactamase substrates having phenolic ethers
08/17/2005CN1656046A Process for producing cyclic compound
08/03/2005CN1213144C Recombination nucleic acid molecule and application thereof
07/2005
07/28/2005US20050165229 Cyclization cepham derivative; 1,4-dihydroxylbut-1-yl side chain is cyclized to form cyclic ether, such as tetrahydrofuranyl system; acid catalyst
06/2005
06/30/2005WO2005058914A1 Crystal of oxacephem
06/02/2005US20050118669 Reporter genes; fluorescence activated cell sorting
02/2005
02/16/2005EP1385853A4 Beta-lactamase substrates having phenolic ethers
12/2004
12/22/2004EP1489061A1 Process for producing cyclic compound
11/2004
11/30/2004US6825344 Process for the preparation of cephalosporin compounds and synthetic intermediates
10/2004
10/12/2004US6803460 Acidification; carbonation
04/2004
04/07/2004EP1405922A2 Substrates for beta-lactamase and uses thereof
02/2004
02/18/2004CN1138781C Process for recovery cephalosporin from fermentative liquid
02/04/2004EP1385853A2 Beta-lactamase substrates having phenolic ethers
12/2003
12/04/2003WO2002068678A3 Beta-lactamase substrates having phenolic ethers
10/2003
10/02/2003WO2003080543A1 Process for producing cyclic compound
07/2003
07/24/2003US20030139595 Novel process for the fermentative production of cephalosporin
07/09/2003CN1113885C Process for producing beta-lactam derivs.
06/2003
06/26/2003US20030119085 Substrates for beta-lactamase and uses thereof
06/18/2003CN1111410C Process for preparation of pharmaceutical composition
04/2003
04/22/2003US6552185 Acidifying and/or contacting with carbon dioxide followed by adsorption chromatography
01/2003
01/02/2003US20030003526 Compound for use in the measurement of gene expression
10/2002
10/30/2002EP1066294B1 Novel process for the fermentative production of cephalosporin
10/29/2002US6472205 Expression control sequences adapted for function in eukaryotic cell, operably linked to sequence coding cytosolic beta-lactamase; screening by contacting host cell with membrane permeable, fluorescent substrate of beta-lactamase
09/2002
09/10/2002CA2087967C Cephalosporins and homologues, preparations and pharmaceutical compositions
09/06/2002WO2002068678A2 Beta-lactamase substrates having phenolic ethers
09/06/2002CA2434679A1 Beta-lactamase substrates having phenolic ethers
05/2002
05/21/2002CA2215310C Substrates for beta-lactamase and uses thereof
05/16/2002US20020058806 Cyclization cepham derivative
03/2002
03/12/2002CA2006769C 2-and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo [1,2,3,-de] -1,4-benzoxazines useful as analgesic agents
02/2002
02/12/2002CA2024399C Compounds
02/06/2002EP1178049A1 Process for the preparation of cephalosporin compounds and intermediates for the synthesis of these compounds
12/2001
12/11/2001US6329363 Cephalosporin antibiotics
09/2001
09/18/2001US6291162 Determining amount of lactamase activity; transfecting cells with a nucleic acid having an expression control sequence linked to a secretion defective sequence; mixing cells with lactamase substrate; determine amount of cleaved substrate
06/2001
06/06/2001CN1066731C Substrates for beta-lactamase and uses thereof
05/2001
05/23/2001CN1296078A Recombination nucleic acid molecule and application thereof
05/16/2001CN1295575A Novel process for fermentative production of cephalosporin
05/01/2001CA2016664C Indole derivative and method of production thereof
04/2001
04/04/2001EP0817785B1 Substrates for beta-lactamase and uses thereof
02/2001
02/13/2001CA2001203C Novel antimicrobial dithiocarbamoyl quinolones
01/2001
01/30/2001CA2030361C 3-fluorosulfonyloxyceph-3-em displacement process
01/24/2001CN1061046C Process for preparing cephalosporins derivants
01/10/2001EP1066294A1 Novel process for the fermentative production of cephalosporin
12/2000
12/19/2000CA2001225C Antimicrobial lactam-quinolones
10/2000
10/17/2000CA2001205C Antimicrobial quinolonyl lactams
09/2000
09/05/2000US6114541 Method for the preparation of α-Bromo-Lactam derivatives
06/2000
06/28/2000CN1258297A Process for producing beta-lactam derivs.
1 2 3 4 5 6